Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease

Len Usvyat, Lorien Dalrymple, Franklin W. Maddux

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Summary: Consistent with the increase of precision medicine, the care of patients with end-stage kidney disease (ESKD) requiring maintenance dialysis therapy should evolve to become more personalized. Precise and personalized care is nuanced and informed by a number of factors including an individual's needs and preferences, disease progression, and response to and tolerance of treatments. Technology can support the delivery of more precise and personalized care through multiple mechanisms, including more accurate and real-time assessments of key care elements, enhanced treatment monitoring, and remote monitoring of home dialysis therapies. Data from health care and non–health care sources and advanced analytical methods such as machine learning can be used to create novel insights, and large volumes of data can be integrated to support clinical decisions. Health care models continue to evolve and the opportunities and need for novel care approaches supported by technology and health informatics continue to expand as the delivery and organization of health care changes. Ultimately, precise personalized care for ESKD, including dialysis therapy, will become more feasible as the biological, social, and environmental determinants of health are more broadly understood and as advances in science, engineering, and information management create the means to provide truly precise care for ESKD.

Original languageEnglish (US)
Pages (from-to)418-425
Number of pages8
JournalSeminars in Nephrology
Issue number4
StatePublished - Jul 1 2018
Externally publishedYes


  • artificial intelligence
  • dialysis
  • individualized medicine
  • precise personalized care
  • renaldisease
  • Technology

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease'. Together they form a unique fingerprint.

Cite this